Safety Shot has announced the Notice of Allowance of for a U.S. patent that covers its newest clinically-backed formula. The Company’s family of patents aims to corroborate Safety Shot’s advantage in the market which includes being faster at removing alcohol, improving cognitive ability, and reducing impairment by supporting the metabolism of alcohol. The latest patent continues to advance an exciting new category of functionality.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SHOT:
- Safety Shot Announces Notice of Allowance for New Patent to Secure IP and Enforce Clinically Backed Claims
- Safety Shot Secures Funding for Wellness Drink Expansion
- Safety Shot reports President Jordan Schur Invests additional $3.4M
- Safety Shot President Jordan Schur Invests an Additional $3.4 Million in the Company Through His Family Fund, Core 4 Capital Corp.
- Safety Shot Clinical Data Results Confirm Breakthrough in Dramatic Reduction of Morning-After Symptoms Associated with Excessive Drinking